FDA recall D-0477-2017

LEO PHARMA INC · Class III · drug

Product

Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)120 g (50222-501-66) tubes, Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054.

Reason for recall

Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014.

Distribution

Nationwide within US

Key facts

Status
Terminated
Initiation date
2017-01-16
Report date
2017-02-22
Termination date
2017-12-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Madison, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0477-2017